Trial Profile
An Open Label, Active Controlled, Parallel Group Phase I Clinical Trial to Assess the Safety, Tolerability and Immunogenicity of NBP608 in Healthy Adult Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Feb 2019
Price :
$35
*
At a glance
- Drugs NBP 608 (Primary) ; Varicella zoster virus vaccine live
- Indications Herpes zoster; Varicella zoster virus infections
- Focus Adverse reactions
- Sponsors SK Chemicals
- 25 Apr 2017 New trial record